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1. Introduction
   Trypanosomiasis is a debilitating, severe and often fatal 
disease affecting both humans and animal is caused by 
a protozoan parasite called trypanosome. The disease 
is transmitted by bitting flies, which have acquired 
their infection from animals harbouring the pathogenic 
parasites[1-3]. The use of indigenous plant extract and 
conctions has been in practice for a very long time. It 
is as old as the world itself. Mimosa pigra and Ipomoea 
asarifolia are examples of such plants. Claims have been 
made that the roots are sniffed for head colds; a decoction 
of the leafy stem is used as a mouthwash for toothaches, 
and the fruits are used in eye medicines[1]. Apparently, 
it is also used for the treatment of snakebite in Africa[4]. 
In Sumatra, roasted and ground mimosa leaves are made 
into an infusion, which is drunk to treat a weak heart or 
weak pulse[5]. A decoction of dried and ground male and 
female parts are used in the same manner. In Mexico, 
an infusion of mimosa was traditionally used in Mayan 
medicine for treatment of diarrhoea. This knowledge 
led to leaves of mimosa and other legumes being 
phytochemically screened and tested for antimicrobial 
activity[6]. In phytochemical screening, flavonoides, 
quinones, saponins, sterols and tannins were detected in 
mimosa and Ipomoea asarifolia. Extracts of mimosa and 
Ipomoea asarifolia showed antimicrobial activity against 
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four bacteria, Staphylococcus aureus, Bacillus subtilis, 
Pseudomonas aeruginosa and Candida albicans, but not 
Escherichia coli. It was concluded that the use of mimosa, 
Ipomoea asarifolia and the other legumes tested could not 
be justified for treating diarrhoea.
   However, the use of drugs for prevention and treatment 
of the trypanosomiasis has been in existence for many 
decades, but the speed by which the trypanosome 
develop resistance to each drug poses serious challenge 
to this approach in controlling the disease[7]. The use of 
chemoprophylactic drugs is expensive, time consuming 
and thus unsatisfactory to the long time problem of African 
animals’ trypanosomiasis. Hence, a need for investigation 
into cost effective and more efficacious targets such as 
plant extracts that have been believed to have trypanocidal 
effect. Most part of Nigeria belong to the tsetse-fly infested 
belt especially the coastal areas bordering the two major 
rivers, Niger and Benue where the Nupe people are 
concentrated, constitute foci for trypanosomiasis. Over 
the years, these people have learnt from experience, the 
clinical signs of the disease and have developed method 
of treatment through the use of herbal medicine, but the 
efficacy has not been scientifically proven.
   This work attempts to establish the inhibitory 
(trypanocidal) effect of Ipomoea asarifolia and Mimosa 
pigraa used among the Nupe ethnic group of Nigeria to 
treat animal and human trypanosomiasis. But the efficacy 
has not been scientifically proven owing to the current 
interest in the development of novel tryponocidal drug 
from plant product with zero side reactions. We found 
it imperative to initiate this work. In this piece, we 
communicate the tryponocidal activity of Mimosa pigra 
and Ipomoea asarifolia on Trypanosoma evansi (T. evansi).
2. Materials and methods
2.1. Infection of rat with T. evansi
   The parasite T. evansi STIB 731-AA (IL-1392) was 
obtained from the Department of Veterinary Parasitology 
ABU Zaria. Parasites were passaged into a white albino 
rat (donor rat) by intraperitoneal inoculation. The levels of 
parasiteamia of the infected rats were monitored daily. The 
parasitaemia was monitored daily on a wet film preparation 
from tail vein blood. T. evansi was a gift from Dr. P. Audu 
of the Department of Biological Sciences Ahmadu Bello 
University, Nigeria , the parasite strain (T. evansi) STIB 
731-AA (IL-1392).
   Animal-fifteen mature albino rats free from infection 
were purchased from the Department of Pharmacology, 
Ahmadu Bello University, Nigeria.
   The phospholipase activity of T. evansi was determined 
using the egg yolk coagulation method of Habermann and 
Neumann which was modified by Gomes and Pallabi[8]. 
Phospholipase activity was measured quantitatively 
(titration) by the initial rate of free fatty acid produced in 
micro moles per minute. The assay mixture contains 500 
毺L of lecithin, 50 毺L of calcium chloride, and 100 毺L 
of enzyme solution (in phosphate buffer 7.2) to give a total 
volume of 650 毺L. The reaction was always initiated by 
the addition of the enzyme last. Thereafter, the enzyme was 
inactivated by heating at 100 曟 for 1 min. The liberated 
fatty acid was titrated to an end point against 20 mm NaOH 
using phenolphthalein as indicator. The phospholipase A2 
activity was given as the number of moles of free fatty acid 
(average of 3 determination依SD) liberated by 1 mg of the 
enzyme[9].
2.2. Ion exchange chromatography
   The ion exchange was carried out by method described 
by Nok et al[10]. All operations were maintained at about 
4 degree centigrade. The crude enzyme was loaded on a 
buffer (pH 6.8) pre-equilibrated DEAE-cellulose column (2 
cm伊30 cm) and eluted by linear gradient between 0.02 and 
0.3 M phosphate saline buffer (pH 6.8) forty fractions (40) of 
5.0 mL each was collected and assayed for phospholipase 
activity and protein content. The dialysate was labeled as 
partially purified PLA2.  
2.3. Effect of indigenous plant extract on PLA2 activity
   Mimosa pigra  and Ipomea asarifolia  were two 
indigenous plants used traditionally for the treatment of 
trypanosomiasis. Ethanolic extracts of these plants were 
prepared in duplicate vig: 10 mg/mL (10%), 20 mg/mL (20%). 
Initial velocity studies were carried out. Results obtained 
from the initial velocity studies were used to determine KM 
and Ki for the various extracts.
   In all cases, the reaction was initiated by adding the 
enzyme last and the activity was stopped by boiling up to 
90 曟 and measured quantitatively by titration.
2.4. Effect of divalent cations on the activity of PLA2
   The enzyme was assayed for the effect of divalent cations 
at pH 7.2 and all other conditions remaining constant, 
except that, Ca2+, the cofactor required for PLA2 activity 
was replaced with copper, magnesium, and zinc. 
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2.5. Effect of anticoagulant
   Substrate was prepared at concentrations between 2-10 
mg/mL in triplicate. Each preparation was inoculated 
with 100 毺L of PLA2 and the activity assay as described 
previously. Inhibition analysis was made on similar 
preparations in the presence of 5伊10-3 M of EDTA and 
haparin.
2.6. Effect of indigenous plant extract on PLA2 activity
   Mimosa pigra  and Ipomea asarifolia  were two 
indigenous plants used traditionally for the treatment of 
trypanosomiasis. Ethanolic extracts of these plants were 
prepared in duplicate vig: 10 mg/mL (10%), 20 mg/mL (20%). 
Initial velocity studies were carried out. Results obtained 
from the initial velocity studies were used to determine KM 
and Ki for the various extracts.
3. Results
   The inhibition mechanism of the antiicoagulant, heparin 
and EDTA shows noncompetitive pattern of inhibtion 
(Figure 1). 
   Double reciprocal plots of the initial velocity data of 
the inhibition by the extracts revealed a non competitive 
pattern of inhibition for Ipomoea asarifolia and a 
competitive inhibition for Mimosa pigra in a dose fashion 
PLA2 (Figures 2 and 3). Extrapolated inhibition binding 
constant ki were found to be 50.0 毺g/mL and 87.11 毺g/
mL for Ipomoea asarifolia and Mimosa pigra respectively 
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Figure 4. Determination of inhibition constant (Ki) of Ipomea 

























-15           -10          -5           0             5              10            15             20         25
Dixon plot Extract concentration 伊102 mg/mL
Figure 5. Determination of inhibition binding constant (Ki) of 
















   PLA2 has been isolated from various animals and plant 
source such as pancreas, snake and bee venoms and 
reported on platelet and phospholipase A2[8,11,12]. The 
primary structure of human pancreatic PLA2 has been 
reported[11]. A double reciprocal plot for the evaluation 
of inhibition type by Ipomoea asarifolia revealed non-
competitive pattern with Ki values of 9.4 and 16.2 mg/mL, 
respectively. At these concentrations, the physiological 
index of efficiency of the enzyme (Vmax/Km) decreased from 
22.4/h to 16.5 and 9.8/h respectively. The non-competitive 
inhibition pattern suggests that sites other than the active 
31Yusuf Alkali et al./ Journal of Acute Disease (2015)28-31
could be involved in the inhibition. Since pre-incubation 
of the enzyme with Ipomoea asarifolia followed by dialysis 
failed to reverse the inhibition, these suggested that the 
Ipomoea asarifolia-PLA2 interaction involved strong 
covalent forces affecting the structure.  
   The pattern of PLA2 inhibition by the extract of Mimosa 
pigra shows that the active site of the enzyme is involved 
in the inhibitory action and that the extract is likely to 
contain some compounds or small molecules that serve 
as analogues of the PLA2 substrate, by competing for the 
enzyme active site. Since the substrate (lecithin) and 
extract are competing for the same site on the enzyme, 
the KM for the substrate shows an apparent increase in 
the presence of the extract. This can be seen in a double 
reciprocal plots as a shift in the X intercept (-1/Km) and 
in the slope Km/Vmax). The effect of Guiera senegalenses 
against phospholipase A2 revealed various inhibitions of 
the parasites by Guiera senegalences 10%, 20% and 30% which 
depicts a classical competitive inhibition which was dose 
dependent[9].
   PLA2 is a pathological enzyme found in several species 
of protozoa and snake venom[8]. It is known to be toxic to 
cell membrane, causing local cell and tissue damage as 
well as inflammatory effect[8,11,13]. The hydrolysis of the 
glycerophospholipids by sPLA2 has great importance in the 
release of lipid mediators[14]. However, high phospholipase 
activity can lead to pathological implications. More 
recently, the phospholipase activity has been associated 
with angiogenesis, apoptosis and cancer. Arachidonate is 
metabolized into prostaglandins and to leukotrienes, potent 
mediators of immune suppression, cellular proliferation, tumor 
motility as well as invasion regulating tumor vascularization 
and metastasis in animal models. Beside enzymatic activity, 
sPLA2 from snake venoms can be neurotoxic[15], myotoxic[13], 
cardiotoxic and can inhibit platelet aggregation and blood 
coagulation. Thus, PLA2 induce various pharmacological 
effects including myotoxic and anticoagulant effect. The 
inhibition of PLA2 can therefore be significant in ameliorating 
the cell damaging effect by the PLA2 on red blood cells which 
lead to anaemia[10]. The low Ki values obtained for these 
extracts towards this enzymes are an indication of high affinity 
the extract or the active components (present in the plants) 
have for these enzyme and therefore an indication that it 
could be explored to serve as a good source of T. evansi PLA2 
antidote and as well help in designing a novel drug, with high 
efficiency.
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